New stock news | WeCare Probiotics submits listing application to the Main Board of the Hong Kong Stock Exchange.

According to the disclosure on April 29 by the Hong Kong Stock Exchange, Weikang Probiotics (Suzhou) Co., Ltd. (hereinafter referred to as Weikang Probiotics) has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with Guotai Haitong as the exclusive sponsor. The prospectus shows that the company is a leading global biomanufacturing enterprise mainly engaged in the research and development (R&D), production, and sales of probiotic strains. According to data from Frost & Sullivan, the company ranked third in the world in terms of probiotic concentrate production in 2025, and ranked first in Asia. The company is committed to providing companies in the fields of human health (i.e. functional foods and dietary supplements), dairy products, and agriculture with high activity, stability, and functionality probiotic powders, probiotic preparations, and dairy fermentation agents through independently developed probiotic strains and supporting production processes.